Spanish biotechnology makes up 2.8% of global production and is cited 30% more than the global average in this area. Spain is ranked 9th in scientific production in biotechnology and has the highest percentage of scientific papers in high-impact journals of any country: 83.3%.

In 2018, the biotechnology sector invested nearly €770 million in R&D, 71% from biotech companies. Biotech companies were ranked first in Spain in 2018 for R&D investment in industrial sectors, surpassing the pharmaceutical sector for the first time. The year-on-year increase in R&D investment in 2018 was 13%, among the five fastest-growing sectors in R&D investment in Spain.

At AseBio, the Spanish Bioindustry Association, we bring together and represent the interests of companies, associations, foundations, universities, technology and research centers that work in the field of biotechnology in Spain. Our broad membership base, with over 280 members, and our extensive network of national and international collaborations make Asebio the key representative when it comes to designing policies and programmes for encouraging innovation, entrepreneurship and company development in the biotechnology industry, an undisputed vehicle for economic and social growth in Spain.